nPhase raises $30M Series D for AI-native clinical data platform
nPhase has raised $30 million to expand its AI-native clinical data platform internationally. The funding supports a platform built around its Unified Data Management System and statistical computing environment.
Who is affected and how
- pharmaceuticals
- Data management and statistical processing in clinical trials could be automated with AI agents.
Sources
- nPhase Secures $30 Million in Series D Funding to Drive Global Expansion of AI-Native Clinical Data Platform for Life Sciences - BioSpacebiospace.com · Nov 3, 2026
- nPhase rakes in $30M to expand AI-native clinical data platform - Fierce Biotechfiercebiotech.com · Nov 4, 2026
- Bengaluru-based O-Health Raises Funding to Expand Clinical AI Platformdigitalhealthnews.com · Nov 4, 2026
- nPhase Secures $30 Million to Expand AI-Powered Clinical Data Management Platformhlth.com · Nov 4, 2026
- nPhase Raises $30M to Scale AI-Native Clinical Data Fabrics and Agentic Workflows for Life Sciences - HIT Consultanthitconsultant.net · Nov 2, 2026
- nPhase raises $30M for clinical data platform - MobiHealthNewsmobihealthnews.com · Nov 3, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.